Skip to content
GLP-1 Scorecard
Menu
Site position #449

Tell Her Doc

Published by GLP-1 ScorecardUpdated

Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Visit Tell Her DocWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$269/mo (microdose tier, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Not confirmed

Weigh Tell Her Doc against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value28/100
Dose & formulation63/100
Clinical oversight76/100
Labs & monitoring52/100
Fulfillment83/100
Contract terms61/100

Strengths

  • Full compounded GLP-1 lineup — semaglutide and tirzepatide in injection, oral and orally-dissolving-tablet forms, plus microdoses
  • Names its compounding pharmacy partner (Casa Pharma RX), which is independently listed in our pharmacy registry
  • No monthly membership, cancel anytime, free discreet shipping; HSA/FSA eligible with buy-now-pay-later plans
  • Serves patients in all 50 states via a private online consultation

What to consider

  • 'All sales are final' — no refunds once medication has left the pharmacy
  • Exact price is plan-dependent, shown after you pick a product; advertised 'starting at $269', with a lower $140 intro on oral semaglutide
  • References LegitScript but without an independently verifiable seal — we couldn't confirm certification
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Bottom line — Grade C

Best for: Shoppers who want women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy.

Site position #449 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Tell Her Doc — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Tell Her Doc's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Tell Her Doc's site. Not medical advice; see our disclosure.

← Back to the scorecard